OR WAIT null SECS
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
First-time generic drug approvals: Nadolol/bendroflumethiazide and ciprofloxacin
• First-time generic approvals
Nadolol/bendroflumethiazide tablets, 40/5 mg and 80/5 mg (equiv to Corzide tablets)
IMPAX
Ciprofloxacin extended-release tablets, 500 and 1,000 mg (equiv to Cipro XR tablets)
MYLAN